5 things to watch on the ASX on Monday

The benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) ended a disappointing week with a small decline on Friday.

Will the market be able to bounce back with a move higher on Monday? Here are five things to watch:

ASX futures pointing higher.

According to the latest SPI futures, the Australian share market is expected to open the day higher on Monday. Futures are pointing to the market opening the day 21 points or 0.3% higher following a positive end to the week on Wall Street. The Dow Jones rose 0.54%, the S&P 500 climbed 0.46%, and the Nasdaq was 0.1% higher.

Oil prices slide lower.

Energy shares could come under a little bit of pressure on Monday after oil prices took a hit on Friday. According to Bloomberg, the WTI crude oil price fell 0.7% to US$68.49 a barrel and the Brent crude oil price slipped 0.3% to US$73.21 a barrel.

Amcor eyes major acquisition.

The AFR is reporting that packaging giant Amcor Limited (ASX: AMC) is planning to make a $7 billion acquisition of US-based rival Bemis Company through an all-scrip deal. Sources have stated that a deal will be signed this week and is likely to result in a US-listing for Amcor.

Goldman Sachs reiterates buy ratings on infant formula companies.

A note out of Goldman Sachs relating to the Chinese consumer market reveals that it remains positive on A2 Milk Company Ltd (ASX: A2M) and Bellamy’s Australia Ltd (ASX: BAL). The broker has a buy rating on both and believes they remain well placed with their “key differentiating factors (niche offering, premium product and strong brands) and to benefit from consolidation opportunities and emerging demand for premium and niche products.” Goldman remains neutral on Blackmores Limited (ASX: BKL).

Earnings season week two kicks off.

Week two of earnings season is here and will see the likes of AMP Limited (ASX: AMP), Crown Resorts Ltd (ASX: CWN), and REA Group Limited (ASX: REA) report their respective results later this week. We’re set for a quiet start on Monday, though, due to the public holiday in New South Wales.

The ASX small cap up 285% with no sign of stopping...

One Australian company has developed a state of the art device that's revolutionizing hospitals all over the world. Even better, this device is so profitable that the company rakes in 90% margins. That's a lot of cash. So no wonder the stock's up 285% since 2008 – with no signs of stopping...

To discover the name and code, simply click the link below. You'll discover our expert's #1 medical technology pick... and you can decide for yourself whether to get invested today.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited and Crown Resorts Limited. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!